Claudia PARISI, MD

Medical Oncologist & PhD student | Passionate about lung cancer, investigational cancer therapeutics, gender-related disparities and digital health.

[Claudia PARISI, MD @PARISImd]

Amazed to be part of this wonderful community of lung research enthusiasts 🫁 #WCLC25 @ChristianRolfo @FCappuzzo @DeboraBrascia @RobertoBoreaMD @MehmetAltanMD @Al3ssandroRusso @marinagarassino @fede_pezz86 and many others ⭐️

[Claudia PARISI, MD @PARISImd]

@ValenzaCarmine @AACR @DFCI_BreastOnc @IEOufficiale ENORMEMENTE BRAVOOOO! 🤩

[BMJ Oncology @BMJOncology]

Important new study in BMJ Oncology

[Claudia PARISI, MD @PARISImd]

@ChristianRolfo @Al3ssandroRusso @isliquidbiopsy @UmbertoMalapel1 Congratulazioni @UmbertoMalapel1 !!!!!!

[d.planchard @dplanchard]

Thank you, Claudia @ClaudiaParisi18 , for these 4 years with us at @GustaveRoussy You have been an invaluable help to the team and our Lung pts. Thank you for your unwavering work and the Italian cheerfulness you brought us. Wishing you all the very best for your future in Nice!

[ACS Journal Cancer @JournalCancer]

📗 Major advances in the systemic treatment of NSCLC have been made over the past 20 years. CANCER delivers 8 comprehensive reviews on targeted therapies for NSCLC written by leading global experts in this recent supplement: https://t.co/ISLsd26zZA

@OncoAlert #LCSM

[Claudia PARISI, MD @PARISImd]

Coming soon at #ESMO25 our study on gender disparities in RPM and SDH across cancer pts in 110 centres
@Resiliencecare @barlesi @GustaveRoussy
My research is now moving towards digital solutions exploitation to study and mitigate gender-related BiAbs tox experience in NSCLC.

[Hidehito HORINOUCHI @HHorinouchi]

🔥Congratulations🎊
🎖️ @IASLC Academy Mentors & Participants🌟
👥 @RManochakian @ChristianRolfo @maraantonoff @JairBar4 @JessicaJLinMD @triparnasen @acmoorephd @ZerAlona @fabiomoraesmd @ElinardouHelena @BalazsHalmosMD @LuisRaezMD @Piuchagarrido and more
@OncoAlert #LCSM #WCLC25

[Adrien Rousseau @arousseaumd]

I'm happy to share our new publication 📝 : https://t.co/BIXlhbkWLP
In this cohort study, including more than 40,000 patients with #NSCLC
At immunotherapy start, we found a association between survival and prescription of : Antibiotic, PPI &High dose of steroid
@BenjaminBesseMD

[Claudia PARISI, MD @PARISImd]

@NReguart And also falling to the ground in the House of the Spirits🤣🤣🤣

[Claudia PARISI, MD @PARISImd]

@RobertoBoreaMD @IASLC Thank you @RobertoBoreaMD looking forward to meeting you soon for some gender-oriented projects ☕️ stay tuned🤓

[Claudia PARISI, MD @PARISImd]

@RobertoBoreaMD @ChristianRolfo @IASLC @UmbertoMalapel1 Yes, you must be proud of this terrific mentors @UmbertoMalapel1 @ChristianRolfo ✨ Bravo!!🙌

[Claudia PARISI, MD @PARISImd]

Need to implement gender-informed RPM strategies towards
cancer care equity.
Come and visit our poster at row 25
#WCLC25 @barlesi @GustaveRoussy @ines_vazluis @Resiliencecare

[Claudia PARISI, MD @PARISImd]

Being selected as a participant in the 2025 IASLC Academy has been a unique opportunity to advance my professional path within an international community of leaders and mentees in the field of thoracic oncology! Amazed by this exciting experience 💫

[Rami Manochakian MD, FASCO Cancer Education @RManochakian]

🚨🔥The future of #ThoracicOncology is in GREAT hands!

The 2025 @IASLC #Academy Workshop (& final meeting) with OUTSTANDING group of #EarlyCareer #Physicians & #Researchers at #WCLC25.

Honored to serve as academy co-chair with my amazing friend @ChristianRolfo & GREAT faculty.

[Claudia PARISI, MD @PARISImd]

@RManochakian @IASLC @ChristianRolfo Thank you all for this amazing opportunity 💫

[Claudia PARISI, MD @PARISImd]

MTAP expression by immunohistochemistry: a novel biomarker in non-small cell cancer of the lung - Journal of Thoracic Oncology https://t.co/Iaav9D8xga

[Claudia PARISI, MD @PARISImd]

In Italy we have one of the most recognized hepatobiliary surgeon, well known for his contributions to liver surgery in the field of oncologic liver resection and minimally invasive techniques.
I met him and I was very impressed from his humanity, kindness and honesty 💎

[GUIDO TORZILLI @TorzilliGuido]

Pleased to announce the release of another scaffold sparing solution for boosting one stage removal of multiple bilobar colorectal liver metastases: SLICED LIVER HEPATECTOMY
@HumanitasMilano @HUNIMED
@IHPBA @AHPBA @EAHPBA @APHPBA @IASGO_1988 @SSATNews @SocSurgOnc @Aicep4

[Laurence Albiges @AlbigesL]

Thanks #ASCO25 for the amazing opportunity to present some of the @GustaveRoussy works

@FAndreMD @barlesi @drcmassard @BenjaminBesseMD @dplanchard @BarbaraPistill2 @EmelineColomba @JordiRemon @HollebecqueA @Ribeiro2M @MichelsJudith @derosa__lisa and many more !

[Claudia PARISI, MD @PARISImd]

FRONT-BRAF: 1L immunotherapy +/- chemo vs. BRAF + MEK inhibitors in mNSCLC presented by my friend and colleague @DiFedericoMD a very kind-hearted, dedicated thoracic oncologist with a bright future ahead 🌟 🇮🇹 🇺🇸 #ASCO25 https://t.co/8DNk6mhjAE via @YouTube

[Claudia PARISI, MD @PARISImd]

@DiFedericoMD presenting FRONT-BRAF: 1L immunotherapy +/- chemo vs. BRAF + MEK inhibitors in mNSCLC https://t.co/LELN5ZU5aE via @YouTube
A kind-hearted and dedicated oncologist/researcher with a bright future ahead 🌟 truly a pleasure having met him on 🇮🇹 path